Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site, Prospective, Two-Part Longitudinal, Observational Cohort Study Of Pregnant Women To Evaluate Biomarkers For Prediction Of Pregnancy Complications

NCT07669935 is registered in ClinicalTrials.gov with Medicines360 as lead sponsor.

NCT NCT07669935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07669935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site, Prospective, Two-Part Longitudinal, Observational Cohort Study Of Pregnant Women To Evaluate Biomarkers For Prediction Of Pregnancy Complications
Lead sponsor
Medicines360
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2026
Completion date
December 1, 2028
Enrollment
5,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction (fgr), gdm, preeclampsia, pregnancy complications, preterm preeclampsia